Welcome to the “news” section of our website, where you'll find all the latest publications on our advances in research (Alzheimer's, Parkinson's, Charcot's disease, etc.), our upcoming events, etc.
Glioblastomas are the most common malignant tumors of the adult brain. They resist conventional treatment, including surgery, followed by radiation therapy and chemotherapy. Despite thisarmamentarium, glioblastomas inexorably recur. In a new study...
A high tumour mutational burden (hypermutation) is observed in some gliomas 1, 2, 3, 4, 5; however, the mechanisms by which hypermutation develops and whether it predicts the response to immunotherapy are poorly understood.
Teams from the Assistance Publique-Hôpitaux de Paris, the Pierre and Marie Curie University, the Inserm and the CarThera company, hosted at the Brain and Spine Institute (Institut du Cerveau - ICM), coordinated by professor Alexandre Carpentier...
Today, in France, about 5000 new carriers of malignant primary brain tumours are diagnosed each year. The symptoms depend on the localization of the tumour, its size and the rate at which it develops. Gliomas represent around 50-60% of all primary...
